InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Discover the full record of transactions filed by Dube Eric M, Chief Executive Officer. Officer active across 1 company, notably Travere Therapeutics, Inc.. Cumulatively, 12 filings have been recorded. Split: 0 buy · 8 sells. Total volume traded: €959k. History available since 1 June 2021. The latest transaction was filed on 10 February 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
4,832 shares@ US$27.840.0030% mcap12.3% of flowCommon StockSEC:0001209191-22-008818:0
4,832 shares@ US$27.840.0030% mcap24.6% of flowCommon StockSEC:0001209191-22-008818
37,848 shares0Common StockSEC:0001209191-22-006357:0
37,848 shares0Common StockSEC:0001209191-22-006357
7,873 shares@ US$24.980.0044% mcap18.1% of flowCommon StockSEC:0001209191-22-005078:0
7,873 shares@ US$24.980.0044% mcap36.2% of flowCommon StockSEC:0001209191-22-005078
4,832 shares@ US$30.430.0033% mcap13.6% of flowCommon StockSEC:0001209191-22-002156:0
4,832 shares@ US$30.430.0033% mcap27.1% of flowCommon StockSEC:0001209191-22-002156
17,500 shares0Common StockSEC:0001209191-21-052084
17,500 shares0Common StockSEC:0001209191-21-052084:0
4,782 shares@ US$14.890.0015% mcap12.2% of flowCommon StockSEC:0001209191-21-037615
4,782 shares@ US$14.890.0015% mcap6.1% of flowCommon StockSEC:0001209191-21-037615:0
12 of 12 declarations
About Dube Eric M
Eric M. Dube is the Chief Executive Officer of Travere Therapeutics, Inc. He leads the company in developing innovative therapies for rare diseases. Travere Therapeutics is a biopharmaceutical company dedicated to improving patients' lives through therapeutic solutions. Eric M. Dube brings deep expertise in the healthcare sector, guiding the company towards significant advancements in research and development.
